Metabolic Reprogramming of B Cells in Cancer: Effects of Altered Energetics
Open Access
Abstract
B cells, an important component of adaptive immunity, play a key role in defense against a variety of infections and diseases including cancer. B cells play a dual role in cancer, contributing to both anti-tumor immunity and tumor progression. Metabolic reprogramming in the TME has a profound impact on B cell dynamics, reshaping their energetic landscape, influencing their differentiation and effector cell functions. These alterations arise from the complex interplay between intrinsic metabolic pathways and extrinsic factors, such as nutrient availability, hypoxic conditions, and tumor-derived signals. In the TME, B cells promote glycolysis over oxidative phosphorylation (OXPHOS) to meet the high energy demands of activation and proliferation. However, this metabolic plasticity is also mimicked by tumors, leading to dysfunctional B cell phenotypes, such as regulatory B cells (Bregs), which suppress anti-tumor immunity. Nutrient deprivation and accumulation of metabolic byproducts, including lactate, further impair B cell-mediated immune responses. This review highlights the complex interaction between B cell metabolism and cancer, emphasizing the effects of altered energetics on B cell function and implications on tumor progression and therapy. Decoding the metabolic vulnerabilities of B cells in the tumor niche can uncover novel therapeutic strategies against cancer.Keywords
This publication has 176 references indexed in Scilit:
- Tumor‐infiltrating B cells participate in shaping the immunosuppressive microenvironment in solid tumorsInternational Journal of Cancer, 2025
- The role of fatty acid metabolism on B cells and B cell-related autoimmune diseasesInflammation Research, 2025
- The Combined Inhibition of SREBP and mTORC1 Signaling Synergistically Inhibits B‐Cell LymphomaCancer Medicine, 2024
- Tumor‐derived lactic acid promotes acetylation of histone H3K27 and differentiation of IL‐10‐producing regulatory B cells through direct and indirect signaling pathwaysInternational Journal of Cancer, 2024
- Glucose metabolism in B cell malignancies: a focus on glycolysis branching pathwaysMolecular Oncology, 2024
- Lipid metabolism in B cell biologyMolecular Oncology, 2023
- The tryptophan–kynurenine pathway in immunomodulation and cancer metastasisCancer Medicine, 2023
- Glutamine deficiency promotes stemness and chemoresistance in tumor cells through DRP1-induced mitochondrial fragmentationCellular and Molecular Life Sciences, 2021
- Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumorsCancer Immunology, Immunotherapy, 2020
- The essential role of L‐glutamine in lymphocyte differentiation in vitroJournal of Cellular Physiology, 1985